EC Gastroenterology and Digestive System

Research Article Volume 10 Issue 1 - 2023

A Clinical Study of 80 Sudanese Patients with Microscopic Colitis

Elsadig AA Drweesh1, Sara EA Mohammed Ali2*, Badreldin M Yousif3 and Suleiman S Fedail4

1MD MRCP, Fedail Hospital, Sudan
2Consultant Gastroenterologist, Soba University Hospital, Khartoum, Sudan
3Consultant Histopathologist, Fedail Hospital, Faculty of Medicine, University of Bahri, Khartoum North, Sudan
4Professor of Gastroenterology, Fedail Hospital, Khartoum, Sudan
*Corresponding Author: Sara EA Mohammed Ali, Consultant Gastroenterologist, Soba University Hospital, Khartoum, Sudan.
Received: January 24, 2023; Published: January 31, 2023



Background: Microscopic colitis, a chronic inflammation of the colon characterized by specific histologic changes, normal radiological studies and normal looking colonic mucosa on endoscopy. It is a common cause of chronic non-bloody diarrhea that occurs primarily in older individuals.

Aim of the Study: To evaluate the clinical features, risk factors, endoscopic and histopathology of microscopic colitis in a Sudanese population.

Methods: A retrospective study conducted in Fedail hospital, Khartoum, Sudan. Adult patients diagnosed with microscopic colitis on histopathology between the year 2013 to 2020 were included. Data collected from patient’s medical records attending gastroenterology clinics, endoscopy/histopathology reports and patients were interviewed through phone. The data was analyzed using statistical package for social science SPSS, V. 21.0. IBM; Chicago). P value < 0.05 was considered significant.

Results: Eighty patients with microscopic colitis were enrolled. F\M ratio was 1.3 :1, 58.75% had collagenous variant and 41.25% had lymphocytic variant. Mean age was 43 +/- 14 SD for Lymphocytic Colitis variant and 56 +/- 17 SD for collagenous colitis variant. Common symptoms were chronic watery diarrhea 92.5%, nocturnal diarrhea 67.5%, abdominal pain 50%, fecal incontinence 42.55%, urgency 40%, abdominal distention 15.5%, tenesmus 7.5%, fatigue and arthralgia 15%, weight loss 12.5%. Weight loss was noted in 8 patients (10%) with concomitant celiac disease. Endoscopy normal in 96.25%. Risk factors for MC: use of PPI, 29.25%, NSIADs 18.75%, ACE inhibitors 16.25% and statins 10%. Dairy products were linked to MC in 21.25%, thyroid diseases 10% (those were 8 females with hypothyroidism), celiac disease in 10% and smoking 7.5%. No significant correlations between age, gender and MC variant.

Conclusion: The most common type of MC was the Collagenous variant predominantly among middle aged females. Chronic watery diarrhea was a common symptom of MC. PPI and NSAIDs use were encountered as common risk factors for MC.

 

Keywords: Microscopic Colitis; Collagenous Variant; Lymphocytic Variant

  1. Zabana Y., et al. “Advances for improved diagnosis of microscopic colitis in patients with chronic diarrhoea”. Journal of Gastroenterology and Hepatology2 (2017): 107-116.
  2. Lindstrom CG. “Collagenous colitis with watery diarrhoea: a new entity?” The European Journal of Plant Pathology 11 (1976): 87-89.
  3. Aderemi Oluyemi., et al. “Lymphocytic Colitis in Nigeria: A Case Series”. The annals of African Surgery3 (2021): 180-184.
  4. , et al. “Lymphocytic colitis presenting as difficult diarrhoea in an African woman: a case report and review of the literature”. Journal of Medical Case Reports 4 (2010): 31.
  5. Schiller LR. “Diagnosis and management of microscopic colitis syndrome”. Journal of Clinical Gastroenterology5-1 (2004): S27-S30.
  6. Pardi DS., et al. “The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota”. Gut 56 (2007): 504-508.
  7. M Olesen., et al. “Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients”. Gut 53 (2004): 536-541.
  8. Münch A., et al. “Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group”. Journal of Crohn's and Colitis9 (2012): 932-945.
  9. Guagnozzi D., et al. “Systematic review with metaanalysis: diagnostic overlap of microscopic colitis and functional bowel disorders”. Alimentary Pharmacology and Therapeutics 43 (2016): 851-862.
  10. Hilpusch F., et al. “Microscopic colitis: a missed diagnosis among patients with moderate to severe irritable bowel syndrome”. Scandinavian Journal of Gastroenterology 52 (2017): 173-177.
  11. Bohr J., et al. “Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients”. Gut6 (1996): 846-851.
  12. Fine KD., et al. “High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome”. The American Journal of Gastroenterology 95 (2000): 1974-1982.
  13. Clara AP., et al. “Microscopic colitis: a literature review”. Revista da Associação Médica Brasileira - SciELO9 (2016): 895-900.

Sara EA Mohammed Ali., et al. “A Clinical Study of 80 Sudanese Patients with Microscopic Colitis”. ”. EC Gastroenterology and Digestive System  10.1 (2023): 13-20.